Beatriz Wills

819 total citations
30 papers, 497 citations indexed

About

Beatriz Wills is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Beatriz Wills has authored 30 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Beatriz Wills's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (8 papers) and Colorectal Cancer Treatments and Studies (5 papers). Beatriz Wills is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (8 papers) and Colorectal Cancer Treatments and Studies (5 papers). Beatriz Wills collaborates with scholars based in Colombia, United States and Spain. Beatriz Wills's co-authors include Alexander M. Lesokhin, Kitsada Wudhikarn, Andrés F. Cardona, Óscar Arrieta, Carlos Vargas, Hernán Carranza, Yelena Y. Janjigian, Viswatej Avutu, Melissa Lumish and Rimma Belenkaya and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Beatriz Wills

25 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beatriz Wills Colombia 11 313 147 99 99 72 30 497
Shangqian Wang China 13 58 0.2× 95 0.6× 157 1.6× 53 0.5× 45 0.6× 19 431
Grace H. Tang Canada 11 128 0.4× 52 0.4× 90 0.9× 26 0.3× 76 1.1× 42 364
Christelle Clément-Duchêne France 15 379 1.2× 391 2.7× 196 2.0× 7 0.1× 73 1.0× 53 804
Alain Monnereau France 16 315 1.0× 82 0.6× 76 0.8× 4 0.0× 97 1.3× 35 814
Joseph F. Fraumeni United States 9 194 0.6× 128 0.9× 89 0.9× 12 0.1× 78 1.1× 9 701
Amy C. MacArthur Canada 11 117 0.4× 78 0.5× 86 0.9× 7 0.1× 71 1.0× 17 454
Hilary Cain United States 11 103 0.3× 261 1.8× 81 0.8× 20 0.2× 17 0.2× 22 543
Gilles Clapisson France 10 330 1.1× 65 0.4× 82 0.8× 7 0.1× 36 0.5× 22 559
Neyran Kertmen Türkiye 11 333 1.1× 100 0.7× 90 0.9× 13 0.1× 150 2.1× 56 491

Countries citing papers authored by Beatriz Wills

Since Specialization
Citations

This map shows the geographic impact of Beatriz Wills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Wills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Wills more than expected).

Fields of papers citing papers by Beatriz Wills

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Wills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Wills. The network helps show where Beatriz Wills may publish in the future.

Co-authorship network of co-authors of Beatriz Wills

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Wills. A scholar is included among the top collaborators of Beatriz Wills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Wills. Beatriz Wills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Victoria, Jorge, Juan Esteban García-Robledo, Alexandrе Loukanov, et al.. (2025). Advancing CAR-T cell manufacturing in Latin America: Current landscape, future directions, and challenges. Critical Reviews in Oncology/Hematology. 217. 105041–105041.
2.
Devlin, Sean M., Beatriz Wills, Amethyst Saldia, et al.. (2023). Comparison of Bendamustine Versus Fludarabine/ Cyclophosphamide Lymphodepletion in Adult Patients Receiving CD19 CAR-T Cell Therapy. Blood. 142(Supplement 1). 3510–3510. 1 indexed citations
3.
4.
Jee, Justin, Aaron J. Stonestrom, Sean M. Devlin, et al.. (2021). Oncologic immunomodulatory agents in patients with cancer and COVID-19. Scientific Reports. 11(1). 4814–4814. 10 indexed citations
5.
Jee, Justin, Michael B. Foote, Melissa Lumish, et al.. (2020). Chemotherapy and COVID-19 Outcomes in Patients With Cancer. Journal of Clinical Oncology. 38(30). 3538–3546. 173 indexed citations
6.
Wudhikarn, Kitsada, Beatriz Wills, & Alexander M. Lesokhin. (2020). Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action. Best Practice & Research Clinical Haematology. 33(1). 101143–101143. 37 indexed citations
7.
Wills, Beatriz, Julie R. Brahmer, & Jarushka Naidoo. (2018). Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer. Current Treatment Options in Oncology. 19(9). 46–46. 14 indexed citations
8.
Wills, Beatriz, et al.. (2018). Role of liquid biopsies in colorectal cancer. Current Problems in Cancer. 42(6). 593–600. 23 indexed citations
9.
Corrales, Luis, Óscar Arrieta, Luís Más, et al.. (2017). An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP). Lung Cancer. 113. 30–36. 25 indexed citations
10.
Wills, Beatriz, Andrés F. Cardona, Leonardo Rojas, et al.. (2017). Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab. Anticancer Research. 37(11). 6429–6436. 10 indexed citations
11.
Cardona, Andrés F., Óscar Arrieta, Leonardo Rojas, et al.. (2017). P1.02-050 Acquired Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs) in EGFR-Mutant Lung Adenocarcinoma among Hispanics (Rbiop-CLICaP). Journal of Thoracic Oncology. 12(1). S517–S518. 2 indexed citations
12.
Cardona, Andrés F., Óscar Arrieta, Leonardo Rojas, et al.. (2017). Acquired Resistance to Erlotinib in EGFR Mutation-Positive Lung Adenocarcinoma among Hispanics (CLICaP). Targeted Oncology. 12(4). 513–523. 24 indexed citations
13.
Cardona, Andrés F., Óscar Arrieta, Leonardo Rojas, et al.. (2016). O.01: Acquired Resistance to EGFR-TKIs in EGFR-Mutant Lung Adenocarcinoma Among Hispanics (RBIOP-CLICaP). Journal of Thoracic Oncology. 11(10). S168–S168. 1 indexed citations
14.
Rojas, Leonardo, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). PD2.04 (also presented as P1.42): PEM/CBP/BEV Followed by Maintenance PEM/BEV in Hispanic Patients With NSCLC: Outcomes According to TS, ERCC1 and VEGF. Journal of Thoracic Oncology. 11(10). S177–S178. 1 indexed citations
15.
Rojas, Leonardo, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). P1.42 (also presented as PD2.04): PEM/CBP/BEV Followed by Maintenance PEM/BEV in Hispanic Patients With NSCLC: Outcomes According to TS, ERCC1 and VEGF. Journal of Thoracic Oncology. 11(10). S208–S209. 1 indexed citations
16.
17.
Corrales, Luis, Andrés F. Cardona, Óscar Arrieta, et al.. (2016). P2.03: Treatment of Malignant Pleural Mesothelioma Beyond First-Line Among Hispanics (MeSO-CLICaP). Journal of Thoracic Oncology. 11(10). S217–S218. 1 indexed citations
18.
Wills, Beatriz, et al.. (2014). Infarto agudo de miocardio inducido por heroína. Revista Colombiana de Cardiología. 21(5). 327–331.
19.
Wills, Beatriz, et al.. (2010). EVALUACIÓN DE UN CLARIFICADOR DE MANTO DE LODOS A ESCALA DE LABORATORIO. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 7(14). 53–65. 1 indexed citations
20.
Wills, Beatriz, et al.. (1999). Estudio de tratabilidad de las aguas residuales de una planta pulverizadora de leche. Revista Facultad de Ingeniería Universidad de Antioquia. 20–37.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shangqian Wang Breakdown of academic impact, for papers by Grace H. Tang Breakdown of academic impact, for papers by Christelle Clément-Duchêne Breakdown of academic impact, for papers by Alain Monnereau Breakdown of academic impact, for papers by Joseph F. Fraumeni Breakdown of academic impact, for papers by Amy C. MacArthur Breakdown of academic impact, for papers by Hilary Cain Breakdown of academic impact, for papers by Gilles Clapisson Breakdown of academic impact, for papers by Neyran Kertmen
Rankless by CCL
2026